Christina N. Carrigan

A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies

Jutta Deckert, Peter U. Park, Sharon Chicklas et al. · Blood · 2013 · 93 citations

Pharmacy, Oncology, Pharmacology +15

Synthesis and in Vitro Pharmacology of Substituted Quinoline-2,4-dicarboxylic Acids as Inhibitors of Vesicular Glutamate Transport

Christina N. Carrigan, Richard D. Bartlett, C. Sean Esslinger et al. · Journal of Medicinal Chemistry · 2002 · 69 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models

Kathleen R. Whiteman, Holly A. Johnson, Michele Mayo et al. · mAbs · 2014 · 66 citations · Full text

Medicine, Oncology, Pharmacology +17

The engineering of membrane-permeable peptides

Christina N. Carrigan, Barbara Imperiali · Analytical Biochemistry · 2005 · 52 citations

Engineering, Biochemistry, Bioengineering +12

Zinc Is an Essential Cofactor for Type I Isopentenyl Diphosphate:Dimethylallyl Diphosphate Isomerase

Christina N. Carrigan, C. Dale Poulter · Journal of the American Chemical Society · 2003 · 43 citations

Life Sciences, Biochemistry, Molecular Biology +14